• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by UnitedHealth Group Incorporated

    7/23/24 8:33:25 PM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email
    FWP 1 d809300dfwp.htm FWP FWP

    Issuer Free Writing Prospectus

    Filed Pursuant to Rule 433

    Registration Statement No. 333-270279

    July 23, 2024

    UNITEDHEALTH GROUP INCORPORATED

    FINAL TERM SHEET

    Dated July 23, 2024

    $500,000,000 FLOATING RATE NOTES DUE JULY 15, 2026

    $650,000,000 4.750% NOTES DUE JULY 15, 2026

    $1,250,000,000 4.800% NOTES DUE JANUARY 15, 2030

    $1,500,000,000 4.950% NOTES DUE JANUARY 15, 2032

    $2,000,000,000 5.150% NOTES DUE JULY 15, 2034

    $1,500,000,000 5.500% NOTES DUE JULY 15, 2044

    $2,750,000,000 5.625% NOTES DUE JULY 15, 2054

    $1,850,000,000 5.750% NOTES DUE JULY 15, 2064

     

    Issuer:    UnitedHealth Group Incorporated
    Ratings (Moody’s / S&P / Fitch)*:    A2 / A+ / A
    Note Type:    SEC Registered (No. 333-270279)
    Trade Date:    July 23, 2024
    Settlement Date (T+2)**:    July 25, 2024
    Maturity Date:   

    July 15, 2026 (the “Floating Rate 2026 Notes”)

    July 15, 2026 (the “2026 Notes”)

    January 15, 2030 (the “2030 Notes”)

    January 15, 2032 (the “2032 Notes”)

    July 15, 2034 (the “2034 Notes”)

    July 15, 2044 (the “2044 Notes”)

    July 15, 2054 (the “2054 Notes”)

    July 15, 2064 (the “2064 Notes”)

    Principal Amount Offered:   

    $500,000,000 (Floating Rate 2026 Notes)

    $650,000,000 (2026 Notes)

    $1,250,000,000 (2030 Notes)

    $1,500,000,000 (2032 Notes)

    $2,000,000,000 (2034 Notes)

    $1,500,000,000 (2044 Notes)

    $2,750,000,000 (2054 Notes)

    $1,850,000,000 (2064 Notes)


    Price to Public (Issue Price):   

    100% of the Principal Amount (Floating Rate 2026 Notes)

    99.832% of the Principal Amount (2026 Notes)

    99.940% of the Principal Amount (2030 Notes)

    99.773% of the Principal Amount (2032 Notes)

    99.994% of the Principal Amount (2034 Notes)

    99.081% of the Principal Amount (2044 Notes)

    99.801% of the Principal Amount (2054 Notes)

    99.397% of the Principal Amount (2064 Notes)

    Net Proceeds (After Underwriting Discount, Before Expenses) to Issuer:

      

    $499,250,000 (99.850% of the Principal Amount) (Floating Rate 2026 Notes)

    $647,933,000 (99.682% of the Principal Amount) (2026 Notes)

    $1,244,875,000 (99.590% of the Principal Amount) (2030 Notes)

    $1,490,595,000 (99.373% of the Principal Amount) (2032 Notes)

    $1,990,880,000 (99.544% of the Principal Amount) (2034 Notes)

    $1,476,465,000 (98.431% of the Principal Amount) (2044 Notes)

    $2,723,902,500 (99.051% of the Principal Amount) (2054 Notes)

    $1,824,044,500 (98.597% of the Principal Amount) (2064 Notes)

    Interest Rate:   

    Compounded SOFR plus 0.500% (Floating Rate 2026 Notes)

    4.750% (2026 Notes)

    4.800% (2030 Notes)

    4.950% (2032 Notes)

    5.150% (2034 Notes)

    5.500% (2044 Notes)

    5.625% (2054 Notes)

    5.750% (2064 Notes)


    Interest Payment Dates:   

    January 15, April 15, July 15 and October 15, commencing October 15, 2024 (Floating Rate 2026 Notes)

    January 15 and July 15, commencing January 15, 2025 (2026 Notes)

    January 15 and July 15, commencing January 15, 2025 (2030 Notes)

    January 15 and July 15, commencing January 15, 2025 (2032 Notes)

    January 15 and July 15, commencing January 15, 2025 (2034 Notes)

    January 15 and July 15, commencing January 15, 2025 (2044 Notes)

    January 15 and July 15, commencing January 15, 2025 (2054 Notes)

    January 15 and July 15, commencing January 15, 2025 (2064 Notes)

    Regular Record Dates:   

    The 15th calendar day (whether or not a business day) immediately preceding the applicable interest payment date (Floating Rate 2026 Notes)

    January 1 and July 1 (2026 Notes)

    January 1 and July 1 (2030 Notes)

    January 1 and July 1 (2032 Notes)

    January 1 and July 1 (2034 Notes)

    January 1 and July 1 (2044 Notes)

    January 1 and July 1 (2054 Notes)

    January 1 and July 1 (2064 Notes)

    Benchmark Treasury:   

    N/A (Floating Rate 2026 Notes)

    T 4.625% due June 30, 2026 (2026 Notes)

    T 4.250% due June 30, 2029 (2030 Notes)

    T 4.250% due June 30, 2031 (2032 Notes)

    T 4.375% due May 15, 2034 (2034 Notes)

    T 4.625% due May 15, 2044 (2044 Notes)

    T 4.250% due February 15, 2054 (2054 Notes)

    T 4.250% due February 15, 2054 (2064 Notes)

    Benchmark Treasury Price / Yield:   

    N/A (Floating Rate 2026 Notes)

    100-07 3⁄4 / 4.491% (2026 Notes)

    100-12 1⁄4 / 4.163% (2030 Notes)

    100-12 / 4.187% (2032 Notes)

    100-31+ / 4.251% (2034 Notes)

    100-19+ / 4.577% (2044 Notes)

    96-03+ / 4.489% (2054 Notes)

    96-03+ / 4.489% (2064 Notes)


    Spread to Benchmark Treasury:   

    N/A (Floating Rate 2026 Notes)

    + 35 basis points (2026 Notes)

    + 65 basis points (2030 Notes)

    + 80 basis points (2032 Notes)

    + 90 basis points (2034 Notes)

    + 100 basis points (2044 Notes)

    + 115 basis points (2054 Notes)

    + 130 basis points (2064 Notes)

    Re-offer Yield:   

    N/A (Floating Rate 2026 Notes)

    4.841% (2026 Notes)

    4.813% (2030 Notes)

    4.987% (2032 Notes)

    5.151% (2034 Notes)

    5.577% (2044 Notes)

    5.639% (2054 Notes)

    5.789% (2064 Notes)

     

    Optional Redemption Provisions:   

    The Floating Rate 2026 Notes will not be redeemable prior to maturity.

     

    Make-whole call at any time at a discount rate of U.S. Treasury plus 10 basis points (2026 Notes).

     

    Prior to December 15, 2029 (one month prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 10 basis points; par call on or after December 15, 2029 (2030 Notes).

     

    Prior to November 15, 2031 (two months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 15 basis points; par call on or after November 15, 2031 (2032 Notes).

     

    Prior to April 15, 2034 (three months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 15 basis points; par call on or after April 15, 2034 (2034 Notes).

     

    Prior to January 15, 2044 (six months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 15 basis points; par call on or after January 15, 2044 (2044 Notes).

     

    Prior to January 15, 2054 (six months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 20 basis points; par call on or after January 15, 2054 (2054 Notes).

     


       Prior to January 15, 2064 (six months prior to their maturity date), make-whole call at any time at a discount rate of U.S. Treasury plus 20 basis points; par call on or after January 15, 2064 (2064 Notes).
    Change of Control:    If a Change of Control Triggering Event occurs, the Company will be required to make an offer to repurchase the Notes at a price equal to 101% of the principal amount of the Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.
    Day Count:   

    Fixed Rate Notes: 30/360

    Floating Rate 2026 Notes: Actual/360

    CUSIP / ISIN:   

    91324P FE7 / US91324PFE79 (Floating Rate 2026 Notes)

    91324P FF4 / US91324PFF45 (2026 Notes)

    91324P FG2 / US91324PFG28 (2030 Notes)

    91324P FH0 / US91324PFH01 (2032 Notes)

    91324P FJ6 / US91324PFJ66 (2034 Notes)

    91324P FK3 / US91324PFK30 (2044 Notes)

    91324P FL1 / US91324PFL13 (2054 Notes)

    91324P FM9 / US91324PFM95 (2064 Notes)

    Joint Book-Running Managers:   

    Wells Fargo Securities, LLC

    Citigroup Global Markets Inc.

    J.P. Morgan Securities LLC

    PNC Capital Markets LLC

    RBC Capital Markets, LLC

    U.S. Bancorp Investments, Inc.

     

    Barclays Capital Inc.

    BNP Paribas Securities Corp.

    BofA Securities, Inc.

    Deutsche Bank Securities Inc.

    Goldman Sachs & Co. LLC

    Mizuho Securities USA LLC

    Morgan Stanley & Co. LLC

    TD Securities (USA) LLC

    Truist Securities, Inc.

    Senior Co-Managers:   

    BNY Mellon Capital Markets, LLC

    KeyBanc Capital Markets Inc.

    Santander US Capital Markets LLC

    Scotia Capital (USA) Inc.

    SG Americas Securities, LLC

    SMBC Nikko Securities America, Inc.


    Co-Managers:   

    Bancroft Capital, LLC

    Drexel Hamilton, LLC

    Fifth Third Securities, Inc.

    Huntington Securities, Inc.

    Loop Capital Markets LLC

    Regions Securities LLC

    R. Seelaus & Co., LLC

     

    *

    Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision, suspension or withdrawal at any time.

    **

    We expect that delivery of the Notes will be made against payment therefor on or about July 25, 2024, which will be the second business day following the date of pricing of the Notes (this settlement cycle being referred to as “T+2”). Under Rule 15c6-1 of the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes on any date prior to the date that is one business day preceding the settlement date will be required, by virtue of the fact that the Notes initially will settle in T+2, to specify an alternative settlement cycle at the time of any such trade to prevent a failed settlement and should consult their own advisors.

    * * *

    The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Wells Fargo Securities, LLC toll-free at (800) 645-3751, Citigroup Global Markets Inc. toll-free at (800) 831-9146, J.P. Morgan Securities LLC collect at (212) 834-4533, PNC Capital Markets LLC toll-free at (855) 881-0697, RBC Capital Markets, LLC toll-free at (866) 375-6829 or U.S. Bancorp Investments, Inc. toll-free at (877) 558-2607.

    Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.

    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    6/11/2025$312.00Outperform → Neutral
    Robert W. Baird
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $UNH
    SEC Filings

    See more
    • SEC Form 8-K filed by UnitedHealth Group Incorporated

      8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      6/20/25 4:44:03 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form 424B5 filed by UnitedHealth Group Incorporated

      424B5 - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      6/18/25 5:00:15 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form FWP filed by UnitedHealth Group Incorporated

      FWP - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      6/17/25 5:23:28 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Montgomery Rice Valerie Md was granted 43 shares, increasing direct ownership by 0.69% to 6,299 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      6/26/25 4:23:51 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Chief Executive Officer, Optum Conway Patrick Hugh was granted 73 shares, increasing direct ownership by 0.70% to 10,472 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      6/26/25 4:23:44 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Chief Accounting Officer Roos Thomas E was granted 25 shares, increasing direct ownership by 0.09% to 29,524 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      6/26/25 4:23:36 PM ET
      $UNH
      Medical Specialities
      Health Care